FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/22/2019 |
3. Issuer Name and Ticker or Trading Symbol
MATEON THERAPEUTICS INC [ MATN ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 1,492,742(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series A Convertible Preferred Stock | 04/22/2019 | (2) | Common Stock | 7,052,762(1) | (3) | D |
Explanation of Responses: |
1. Reflects securities of the Issuer acquired by the reporting person pursuant to the Agreement and Plan of Merger, effective as of April 22, 2019, by and among the Issuer, Oncotelic Acquisition Corporation and Oncotelic, Inc. The shares were originally issued, under and remain subject to, the terms of a restricted stock arrangement whereby the shares are subject to forfeiture to the Issuer if the reporting person terminates continuous service with the Issuer. One-third of the shares are fully vested, an additional one- third shall vest and no longer be subject to forfeiture on December 27, 2019 and the final one-third shall vest on December 27, 2020, subject to continuation of services. |
2. The Series A Convertible Preferred Stock is convertible at the holder's election and has no expiration date. |
3. Each share of Series A Convertible Preferred Stock is convertible into one thousand (1,000) shares of Common Stock. |
/s/ Fatih Uckun | 05/02/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |